PMID- 10634155 OWN - NLM STAT- MEDLINE DCOM- 20000210 LR - 20190831 IS - 0815-9319 (Print) IS - 0815-9319 (Linking) VI - 14 IP - 12 DP - 1999 Dec TI - No evidence of increased risk of colorectal cancer in individuals heterozygous for the Cys282Tyr haemochromatosis mutation. PG - 1188-91 AB - BACKGROUND AND AIMS: Previous studies have suggested that increased body iron stores and heterozygosity for haemochromatosis are associated with an increased risk of colorectal carcinoma. The aim of this study is to determine if there is an association between (i) colorectal carcinoma and heterozygosity for the Cys282Tyr mutation of the haemochromatosis gene (HFE) and (ii) this mutation and tumour site or stage. METHODS: Two hundred and twenty-nine unselected patients (127 males, 102 females, mean age 68.0 years) with sporadic colorectal carcinoma and 228 controls (145 males, 83 females, mean age 69.7 years) were studied. DNA was tested for the presence of the Cys282Tyr mutation by digestion with Rsa1 and fragments separated by electrophoresis. RESULTS: Twenty-one patients with colorectal cancer and 23 control subjects were heterozygous for the Cys282Tyr mutation of HFE (relative risk 0.90). There was no association between heterozygosity of the Cys282Tyr mutation and tumour site or stage. CONCLUSIONS: Heterozygosity for the Cys282Tyr mutation of HFE does not appear to be a risk factor for colorectal carcinoma. FAU - Macdonald, G A AU - Macdonald GA AD - Department of Medicine, The University of Queensland, Queensland Institute of Medical Research, Brisbane, Australia. g.macdonald@medicine.herston.uq.edu.au FAU - Tarish, J AU - Tarish J FAU - Whitehall, V J AU - Whitehall VJ FAU - McCann, S J AU - McCann SJ FAU - Mellick, G D AU - Mellick GD FAU - Buttenshaw, R L AU - Buttenshaw RL FAU - Johnson, A G AU - Johnson AG FAU - Young, J AU - Young J FAU - Leggett, B A AU - Leggett BA LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Australia TA - J Gastroenterol Hepatol JT - Journal of gastroenterology and hepatology JID - 8607909 RN - 0 (HFE protein, human) RN - 0 (HLA Antigens) RN - 0 (Hemochromatosis Protein) RN - 0 (Histocompatibility Antigens Class I) RN - 0 (Membrane Proteins) RN - 42HK56048U (Tyrosine) RN - K848JZ4886 (Cysteine) SB - IM MH - Aged MH - Chi-Square Distribution MH - Colorectal Neoplasms/*genetics MH - Cysteine/genetics MH - Electrophoresis, Polyacrylamide Gel MH - Female MH - *Genes, MHC Class I MH - HLA Antigens/*genetics MH - Hemochromatosis/*genetics MH - Hemochromatosis Protein MH - Heterozygote MH - Histocompatibility Antigens Class I/*genetics MH - Humans MH - Male MH - *Membrane Proteins MH - Mutation MH - Polymerase Chain Reaction MH - Risk Factors MH - Tyrosine/genetics EDAT- 2000/01/14 00:00 MHDA- 2000/01/14 00:01 CRDT- 2000/01/14 00:00 PHST- 2000/01/14 00:00 [pubmed] PHST- 2000/01/14 00:01 [medline] PHST- 2000/01/14 00:00 [entrez] AID - 10.1046/j.1440-1746.1999.02027.x [doi] PST - ppublish SO - J Gastroenterol Hepatol. 1999 Dec;14(12):1188-91. doi: 10.1046/j.1440-1746.1999.02027.x.